InsiderClue
Insiders · Profile

DAWES KAREN A

Director at REPLIGEN · Director at Barinthus Biotherapeutics. Filing since 1 Dec 2008. CIK 0001261506

RGEN REPLIGEN CORP Director · 27 trades BRNS Barinthus Biotherapeutics plc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
RGEN REPLIGEN CORP
17 Dec 2025
Director
Sold at will
275
$44.28K
0.3%
RGEN REPLIGEN CORP
27 Feb 2024
Director
Sold at will
1,000
$193.35K
1.1%
RGEN REPLIGEN CORP
29 Aug 2023
Director
Sold at will
850
$145.67K
1.0%
RGEN REPLIGEN CORP
9 Sep 2022
Director
Sold, plan not stated
775
$176.06K
1.0%
RGEN REPLIGEN CORP
25 May 2022
Director
Sold, plan not stated
14,715
$2.21M
16.1%
RGEN REPLIGEN CORP
10 Nov 2021
Director
Sold, plan not stated
4,783
$1.26M
5.0%
RGEN REPLIGEN CORP
2 Nov 2021
Director
Sold, plan not stated
2,400
$729.47K
2.6%
RGEN REPLIGEN CORP
14 Sep 2021
Director
Sold, plan not stated
274
$80.63K
0.3%
RGEN REPLIGEN CORP
1 Sep 2021
Director
Sold, plan not stated
3,459
$982.06K
3.6%
RGEN REPLIGEN CORP
18 Aug 2021
Director
Sold, plan not stated
1,402
$363.17K
1.5%
RGEN REPLIGEN CORP
18 Aug 2021
Director
Bought
40
$10.49K
0.0%
RGEN REPLIGEN CORP
17 Aug 2021
Director
Sold, plan not stated
17,514
$4.44M
15.5%
RGEN REPLIGEN CORP
20 Jul 2021
Director
Sold, plan not stated
4,585
$926.60K
3.9%
RGEN REPLIGEN CORP
13 Jul 2021
Director
Bought
1,520
$307.39K
1.3%
RGEN REPLIGEN CORP
11 May 2021
Director
Sold, plan not stated
285
$50.40K
0.2%
BRNS Barinthus Biotherapeutics plc.
4 May 2021
Director
Bought
1,700
$28.90K
opened
RGEN REPLIGEN CORP
18 Jun 2020
Director
Sold, plan not stated
18,705
$2.15M
15.7%
RGEN REPLIGEN CORP
20 May 2020
Director
Sold, plan not stated
517
$72.09K
0.4%
RGEN REPLIGEN CORP
18 May 2020
Director
Sold, plan not stated
1,600
$220.45K
1.3%
RGEN REPLIGEN CORP
20 Apr 2020
Director
Sold, plan not stated
12,200
$1.28M
10.1%
RGEN REPLIGEN CORP
21 Feb 2020
Director
Sold, plan not stated
4,000
$394.79K
3.4%
RGEN REPLIGEN CORP
17 Jun 2019
Director
Sold, plan not stated
1,295
$100.17K
1.1%
RGEN REPLIGEN CORP
11 May 2018
Director
Sold, plan not stated
20,000
$835.94K
17.4%
RGEN REPLIGEN CORP
21 Mar 2017
Director
Sold, plan not stated
2,521
$86.02K
2.6%
RGEN REPLIGEN CORP
21 Jun 2013
Director
Bought
1,000
$7.70K
3.0%
RGEN REPLIGEN CORP
12 Aug 2011
Director
Bought
10,000
$34.95K
7.1%
RGEN REPLIGEN CORP
14 Jun 2011
Director
Bought
4,500
$16.08K
225%
RGEN REPLIGEN CORP
1 Dec 2008
Director
Bought
2,000
$7.00K
4.2%
28 decisions on file.